PortfoliosLab logoPortfoliosLab logo
KEY vs. SNY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

KEY vs. SNY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in KeyCorp (KEY) and Sanofi (SNY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KEY achieves a 7.52% return, which is significantly higher than SNY's -1.94% return. Over the past 10 years, KEY has outperformed SNY with an annualized return of 10.03%, while SNY has yielded a comparatively lower 5.12% annualized return.


KEY

1D
0.42%
1M
1.74%
YTD
7.52%
6M
15.23%
1Y
38.89%
3Y*
33.73%
5Y*
4.07%
10Y*
10.03%

SNY

1D
1.44%
1M
3.95%
YTD
-1.94%
6M
-4.06%
1Y
-5.85%
3Y*
0.15%
5Y*
1.27%
10Y*
5.12%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KEY vs. SNY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
KEY
KeyCorp
7.52%26.22%25.34%-11.53%-21.69%45.92%-14.50%42.72%-24.61%12.74%
SNY
Sanofi
-1.94%4.93%1.09%6.55%0.57%7.00%0.39%20.47%6.06%9.96%

Correlation

The correlation between KEY and SNY is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Jul 2, 2002

0.29

The correlation between KEY and SNY shifts across timeframes, from 0.15 (3 years) to 0.29 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

KEY:

$23.59B

SNY:

$108.43B

EPS

KEY:

$1.78

SNY:

$3.09

PE Ratio

KEY:

12.25

SNY:

14.58

PS Ratio

KEY:

2.12

SNY:

2.33

PB Ratio

KEY:

1.35

SNY:

1.49

Total Revenue (TTM)

KEY:

$11.22B

SNY:

$47.35B

Gross Profit (TTM)

KEY:

$7.20B

SNY:

$34.18B

EBITDA (TTM)

KEY:

$2.51B

SNY:

$12.63B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KEY vs. SNY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KEY
KEY Risk / Return Rank: 8181
Overall Rank
KEY Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
KEY Sortino Ratio Rank: 8181
Sortino Ratio Rank
KEY Omega Ratio Rank: 8080
Omega Ratio Rank
KEY Calmar Ratio Rank: 7878
Calmar Ratio Rank
KEY Martin Ratio Rank: 8080
Martin Ratio Rank

SNY
SNY Risk / Return Rank: 3131
Overall Rank
SNY Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
SNY Sortino Ratio Rank: 2828
Sortino Ratio Rank
SNY Omega Ratio Rank: 2929
Omega Ratio Rank
SNY Calmar Ratio Rank: 3333
Calmar Ratio Rank
SNY Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KEY vs. SNY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for KeyCorp (KEY) and Sanofi (SNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


KEYSNYDifference
Sharpe ratioReturn per unit of total volatility

+1.95

Sortino ratioReturn per unit of downside risk

+2.42

Omega ratioGain probability vs. loss probability

1.30

0.99

+0.31

Calmar ratioReturn relative to maximum drawdown

2.41

-0.27

+2.68

Martin ratioReturn relative to average drawdown

6.55

-0.53

+7.09

KEY vs. SNY - Sharpe Ratio Comparison

The current KEY Sharpe Ratio is 1.78, which is higher than the SNY Sharpe Ratio of -0.18. The chart below compares the historical Sharpe Ratios of KEY and SNY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


KEYSNYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.78

-0.18

+1.95

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.11

0.05

+0.06

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.25

0.22

+0.03

Sharpe Ratio (All Time)

Calculated using the full available price history

0.15

0.21

-0.07

Drawdowns

KEY vs. SNY - Drawdown Comparison

The maximum KEY drawdown since its inception was -87.08%, which is greater than SNY's maximum drawdown of -46.46%. Use the drawdown chart below to compare losses from any high point for KEY and SNY.


Loading charts...

Drawdown Indicators


KEYSNYDifference

Max Drawdown

Largest peak-to-trough decline

-87.08%

-46.46%

-40.62%

Max Drawdown (1Y)

Largest decline over 1 year

-17.76%

-16.70%

-1.06%

Max Drawdown (3Y)

Largest decline over 3 years

-32.21%

-23.37%

-8.84%

Max Drawdown (5Y)

Largest decline over 5 years

-65.23%

-33.52%

-31.71%

Max Drawdown (10Y)

Largest decline over 10 years

-65.23%

-33.52%

-31.71%

Current Drawdown

Current decline from peak

-4.38%

-16.49%

+12.11%

Average Drawdown

Average peak-to-trough decline

-32.89%

-12.19%

-20.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.52%

8.49%

-1.97%

Volatility

KEY vs. SNY - Volatility Comparison

KeyCorp (KEY) and Sanofi (SNY) have volatilities of 7.36% and 7.29%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KEYSNYDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.36%

7.29%

+0.07%

Volatility (6M)

Calculated over the trailing 6-month period

17.24%

15.76%

+1.48%

Volatility (1Y)

Calculated over the trailing 1-year period

24.12%

25.43%

-1.31%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

38.05%

24.77%

+13.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

39.83%

23.46%

+16.37%

Dividends

KEY vs. SNY - Dividend Comparison

KEY's dividend yield for the trailing twelve months is around 3.77%, less than SNY's 5.38% yield.


PositionTTM20252024202320222021202020192018201720162015
KEY
KeyCorp
3.77%3.97%4.78%5.69%4.54%3.24%4.51%3.51%3.82%1.88%1.81%3.83%
SNY
Sanofi
5.38%4.56%4.22%3.83%4.32%3.80%3.61%3.47%4.29%3.82%4.11%3.77%

Financials

KEY vs. SNY - Financials Comparison

This section allows you to compare key financial metrics between KeyCorp and Sanofi. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B12.00B14.00B20222023202420252026
2.73B
11.24B
(KEY) Total Revenue
(SNY) Total Revenue
Values in USD except per share items

KEY vs. SNY - Profitability Comparison

The chart below illustrates the profitability comparison between KeyCorp and Sanofi over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20222023202420252026
67.4%
72.1%
Portfolio components
KEY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, KeyCorp reported a gross profit of 1.84B and revenue of 2.73B. Therefore, the gross margin over that period was 67.4%.

SNY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sanofi reported a gross profit of 8.11B and revenue of 11.24B. Therefore, the gross margin over that period was 72.1%.

KEY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, KeyCorp reported an operating income of 701.00M and revenue of 2.73B, resulting in an operating margin of 25.7%.

SNY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sanofi reported an operating income of 2.27B and revenue of 11.24B, resulting in an operating margin of 20.2%.

KEY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, KeyCorp reported a net income of 522.00M and revenue of 2.73B, resulting in a net margin of 19.1%.

SNY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sanofi reported a net income of 1.61B and revenue of 11.24B, resulting in a net margin of 14.4%.


Frequently Asked Questions


KEY and SNY have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KEY has higher volatility (7.36%) compared to SNY (7.29%). In terms of maximum drawdown, KEY dropped -87.08% vs SNY's -46.46%.

KEY currently has the higher Sharpe Ratio (1.78 vs -0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KEY and SNY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer